| Unknown | Study of Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer NCT03469531 | Zhujiang Hospital | Phase 2 |
| Completed | Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partn NCT03112668 | Rutgers, The State University of New Jersey | N/A |
| Completed | Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations NCT02646319 | Mayo Clinic | EARLY_Phase 1 |
| Completed | Axalimogene Filolisbac (ADXS11-001) High Dose in Women With Human Papillomavirus (HPV) + Cervical Cancer NCT02164461 | Advaxis, Inc. | Phase 1 |
| Terminated | MRI and PET Imaging in Predicting Treatment Response in Patients With Stage IB-IVA Cervical Cancer NCT01992861 | University of Washington | — |
| Completed | Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointe NCT01846520 | City of Hope Medical Center | N/A |
| Completed | Eribulin Mesylate in Treating Patients With Advanced or Recurrent Cervical Cancer NCT01676818 | University of Southern California | Phase 2 |
| Completed | Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Re NCT01266447 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Pa NCT01098630 | Gynecologic Oncology Group | — |
| Completed | Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors NCT01155258 | University of Southern California | Phase 1 |
| Completed | Temsirolimus in Treating Patients With Cervical Cancer That Is Recurrent, Locally Advanced, Metastatic, or Can NCT01026792 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Triapine, Cisplatin, and Radiation Therapy in Treating Patients With Cervical Cancer or Vaginal Cancer NCT00941070 | National Cancer Institute (NCI) | Phase 2 |
| Withdrawn | Proton Beam Radiation Therapy and Cisplatin in Treating Patients With Stage IB, Stage II, Stage III, or Stage NCT01019278 | Abramson Cancer Center at Penn Medicine | Phase 2 |
| Completed | Stereotactic Radiosurgery Using CyberKnife in Treating Women With Advanced or Recurrent Gynecological Malignan NCT01079832 | Case Comprehensive Cancer Center | Phase 2 |
| Terminated | Flexitouch® Home Maintenance Therapy or Standard Home Maintenance Therapy in Treating Patients With Lower-Extr NCT00577317 | Gynecologic Oncology Group | Phase 3 |
| Completed | FDG and FMISO PET Hypoxia Evaluation in Cervical Cancer NCT00559377 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Radiation Therapy and Chemotherapy in Treating Patients With Locally Advanced Cervical Cancer NCT00054444 | Gynecologic Oncology Group | Phase 1 |
| Completed | Fludeoxyglucose (FDG) F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Th NCT00416455 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Completed | Glycoprotein and Glycan in Tissue and Blood Samples of Patients With Stage IB-IVA Cervical Cancer Undergoing S NCT00460356 | Gynecologic Oncology Group | — |
| Completed | Phase I Study of Intravenous Triapine (IND # 68338) in Combination With Pelvic Radiation Therapy With or Witho NCT00335998 | National Cancer Institute (NCI) | Phase 1 |
| Terminated | Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer NCT00262821 | National Cancer Institute (NCI) | Phase 3 |
| Completed | EF5 in Finding Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Cervical, Endometria NCT00107445 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage NCT00104910 | Gynecologic Oncology Group | Phase 1 |
| Completed | Radiation Therapy Plus Cisplatin and Gemcitabine in Treating Patients With Cervical Cancer NCT00068549 | Gynecologic Oncology Group | Phase 1 |
| Completed | Oxaliplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Cervical Cancer NCT00057863 | National Cancer Institute (NCI) | Phase 2 |
| Completed | 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid NCT00031681 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction NCT00030498 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Ane NCT00017004 | Gynecologic Oncology Group | Phase 3 |
| Completed | Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu NCT00004074 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Collecting Tumor Samples From Patients With Gynecological Tumors NCT00897442 | Gynecologic Oncology Group | — |
| Withdrawn | Colposcopy and High Resolution Anoscopy in Screening For Anal Dysplasia in Patients With Cervical, Vaginal, or NCT01313104 | Northwestern University | N/A |